FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.medikation |
| Resource Type | MedicationRequest |
| Id | MedicationRequest-mii-exa-medikation-medication-request-caelyx.json |
| FHIR Version | R4 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: MedicationRequest mii-exa-medikation-medication-request-caelyx
Profile: MII PR Medikation MedicationRequest version: 2027.0.0-ballot
Security Label: test health data (Details: ActReason code HTEST = 'test health data')
R5: Full representation of the dosage instructions (new):
Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion
status: Active
intent: Order
medication: Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1
authoredOn: 2021-12-21 11:41:00+0100
dosageInstruction
timing: Once per 4 weeks
route: Intravenous use
DoseAndRates
Dose[x] 50 mg/m2 BSA (Details: UCUM codemg/m2 = 'mg/m2')
German
Generated Narrative: MedicationRequest mii-exa-medikation-medication-request-caelyx
Profile: MII PR Medikation MedicationRequest version: 2027.0.0-ballot
Security Label: test health data (Details: ActReason code HTEST = 'test health data')
R5: Full representation of the dosage instructions (new):
Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion
status: Active
intent: Order
medication: Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1
authoredOn: 2021-12-21 11:41:00+0100
dosageInstruction
timing: Once per 4 weeks
route: Intravenous use
DoseAndRates
Dose[x] 50 mg/m2 BSA (Details: UCUM codemg/m2 = 'mg/m2')
{
"resourceType": "MedicationRequest",
"id": "mii-exa-medikation-medication-request-caelyx",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/MedicationRequest|2027.0.0-ballot"
],
"security": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
"code": "HTEST",
"display": "test health data"
}
]
},
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationRequest.renderedDosageInstruction",
"valueMarkdown": "Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion"
}
],
"status": "active",
"intent": "order",
"medicationReference": {
"reference": "Medication/mii-exa-medikation-medication-caelyx"
},
"subject": {
"reference": "Patient/mii-exa-medikation-patient"
},
"authoredOn": "2021-12-21T11:41:00+01:00",
"dosageInstruction": [
{
"timing": {
"repeat": {
"frequency": 1,
"period": 4,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://standardterms.edqm.eu",
"code": "20045000",
"display": "Intravenous use"
}
]
},
"doseAndRate": [
{
"doseQuantity": {
"value": 50,
"unit": "mg/m2 BSA",
"system": "http://unitsofmeasure.org",
"code": "mg/m2"
}
}
]
}
]
}